A SU011248 Expanded Access Protocol for Metastatic RCC Patients Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Efficacy
2001-2012
No
Shouki Bazarbashi, MD
Principal Investigator
KFSH&RC, Riyadh, Saudi Arabia
ORA: KFSH&RC, Riyadh, Saudi Arabia
RAC#2061 043
NCT00531544
February 2007
June 2012
Name | Location |
---|